Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Lenoir › NPI 1114974029
Hospital

Caldwell Memorial Hospital, INC.

Caldwell Memorial Hospital, INC. was paid $28.83M by Medicaid between Jan 2018 and Dec 2024, across 189 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 26% of everything it billed.

33Billing provider infoCALDWELL MEMORIAL HOSPITAL, INC.
LENOIR, NC 28645
33aNPI1114974029assigned 05/27/2006
28Total paid$28.83M
24GClaims819,062
24DCodes billed189
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#19 of 92
Median peer was paid$11.47M
This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SHADOWENS, KAREN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018112,426$2.59M
2019119,471$2.79M
202083,015$1.80M
2021115,351$4.15M
2022129,686$5.70M
2023133,259$6.06M
2024incomplete125,854$5.73M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 26% 287,764 261,650 $7.57M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 27,872 26,210 $5.36M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 16,938 15,520 $3.52M
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 9.0% 39,936 37,729 $2.61M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.9% 12,814 12,183 $1.13M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.7% 4,853 4,287 $1.07M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3.2% 22,716 21,689 $931K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.3% 42,066 40,731 $653K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 870 806 $628K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.8% 25,717 17,703 $524K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 3,648 3,447 $431K
70450 Computed tomography, head or brain; without contrast material 1.1% 1,143 1,044 $306K
177 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,690 $249K
36902 <1% 1,057 $245K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,744 $219K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,316 $210K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,504 $210K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,446 $207K
87081 <1% 27,324 $205K
J3490 Unclassified drugs <1% 48,167 $191K
92552 <1% 6,053 $185K
80053 Comprehensive metabolic panel <1% 21,710 $166K
96127 <1% 19,987 $152K
96375 Therapeutic injection; each additional sequential IV push <1% 2,237 $150K
96361 Intravenous infusion, hydration; each additional hour <1% 3,049 $108K
71046 Radiologic examination, chest; 2 views <1% 2,268 $83K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 614 $77K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,312 $74K
36415 Collection of venous blood by venipuncture <1% 34,738 $67K
90837 Psychotherapy session, about an hour <1% 1,578 $60K
81001 <1% 16,343 $52K
87634 <1% 412 $46K
87807 <1% 2,498 $45K
71045 Radiologic examination, chest; single view <1% 1,989 $38K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 446 $38K
73630 <1% 2,312 $35K
96161 <1% 5,257 $35K
80048 Basic metabolic panel (calcium, ionized) <1% 4,525 $34K
84484 <1% 4,616 $33K
99152 <1% 1,437 $31K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,712 $31K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,245 $30K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 369 $29K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 954 $27K
84443 Thyroid stimulating hormone (TSH) <1% 1,741 $27K
80076 <1% 2,504 $26K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,952 $26K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,125 $25K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 525 $25K
81025 <1% 2,836 $23K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,817 $23K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 450 $23K
0002A <1% 418 $22K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 462 $21K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 307 $20K
83690 <1% 3,130 $20K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 675 $19K
83550 <1% 1,580 $19K
0001A <1% 385 $18K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 16 $17K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 44 $16K
82728 <1% 817 $16K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 227 $16K
83036 Hemoglobin; glycosylated (A1C) <1% 1,673 $16K
80061 Lipid panel <1% 1,051 $15K
83540 <1% 1,584 $14K
J7120 Ringers lactate infusion, up to 1000 cc <1% 872 $12K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 14 $11K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $10K
97010 <1% 281 $9K
83735 <1% 1,495 $9K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 49 $9K
J7050 Infusion, normal saline solution, 250 cc <1% 2,144 $9K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 28 $8K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 26 $8K
82607 <1% 452 $8K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 48 $8K
C1769 Guide wire <1% 1,434 $8K
92567 <1% 1,039 $8K
83655 <1% 420 $7K
J1644 Injection, heparin sodium, per 1000 units <1% 3,694 $7K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,399 $6K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,342 $6K
J2704 Injection, propofol, 10 mg <1% 1,446 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 299 $6K
11750 <1% 40 $6K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,192 $6K
81003 <1% 2,204 $5K
93017 <1% 138 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,495 $5K
99243 <1% 201 $5K
76801 <1% 146 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,620 $5K
99406 <1% 776 $4K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 106 $4K
83880 <1% 178 $4K
76830 Ultrasound, transvaginal <1% 56 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 42 $4K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 103 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,775 $3K
85018 <1% 1,394 $3K
0031A <1% 74 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 150 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 816 $3K
11730 <1% 62 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 75 $3K
84439 <1% 266 $3K
86300 <1% 106 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 80 $3K
93923 <1% 29 $3K
73130 <1% 38 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 48 $2K
72110 <1% 66 $2K
73030 <1% 42 $2K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 504 $1K
0072A <1% 26 $1K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 264 $1K
82378 <1% 47 $1K
85610 <1% 250 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 41 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 39 $1K
85027 <1% 163 $1K
51798 <1% 166 $993.68
C1760 Closure device, vascular (implantable/insertable) <1% 13 $977.40
82962 <1% 1,470 $966.38
90834 Psychotherapy session, about 45 minutes <1% 37 $955.76
0004A <1% 15 $927.87
0012A <1% 15 $910.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 97 $905.74
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 36 $875.00
86671 <1% 35 $871.80
90791 Psychiatric diagnostic evaluation <1% 32 $769.76
J8597 Antiemetic drug, oral, not otherwise specified <1% 175 $664.09
0071A <1% 17 $644.22
20610 <1% 28 $565.76
83615 <1% 63 $521.27
84132 <1% 729 $511.09
84480 <1% 25 $453.19
J2270 Injection, morphine sulfate, up to 10 mg <1% 117 $443.57
87420 <1% 31 $442.68
0011A <1% 22 $429.34
83605 <1% 40 $412.61
87040 <1% 16 $411.76
92579 <1% 43 $408.16
73610 <1% 16 $407.30
J2785 Injection, regadenoson, 0.1 mg <1% 37 $390.81
94664 <1% 12 $377.88
94642 <1% 12 $377.88
87186 <1% 49 $373.74
85055 <1% 15 $365.66
92553 <1% 13 $358.92
87070 <1% 92 $346.60
31575 <1% 15 $342.72
84702 <1% 30 $283.95
85730 <1% 81 $282.08
86140 <1% 39 $278.62
88141 <1% 14 $278.26
87077 <1% 38 $258.50
58300 <1% 13 $257.92
90715 <1% 13 $241.62
81002 <1% 142 $233.95
0003A <1% 22 $210.85
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 271 $199.43
86036 <1% 27 $185.05
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 17 $184.81
87205 <1% 94 $171.54
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 57 $168.46
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 88 $161.42
J2550 Injection, promethazine hcl, up to 50 mg <1% 62 $160.43
J1170 Injection, hydromorphone, up to 4 mg <1% 31 $158.26
76937 <1% 47 $153.08
90656 <1% 14 $135.57
A9270 Non-covered item or service <1% 3,467 $113.54
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 13 $94.89
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 30 $91.49
82550 <1% 80 $89.21
J1790 Injection, droperidol, up to 5 mg <1% 12 $65.31
99153 Mod sedat endo service >5yrs <1% 17 $64.71
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 14 $59.22
90686 <1% 30 $36.53
82948 <1% 14 $11.56
91300 <1% 1,188 $3.25
91307 <1% 75 $1.30
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 28 $0.90
36416 0% 414 $0.00
91303 0% 74 $0.00
91301 0% 45 $0.00
G0008 Administration of influenza virus vaccine 0% 18 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 247 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHADOWENS, KAREN (CFO)
Same official

Other billing entities under SHADOWENS, KAREN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.